Cyclica to use Excelra’s GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
This post was adapted from its original source on PRNewswire and can be viewed here. HYDERABAD & TORONTO – (October 21, 2020) – Excelra, a leading global Data & Analytics organization, today announced that it has licensed its Global Online Structure Activity Relationship Database (GOSTAR) to Cyclica Inc., a leading biotechnology company whose AI-augmented integrated platform enables […]
Cyclica Receives a $2.0M Grant from FedDev Ontario to Advance Health Innovation
This post was adapted from its original source and can be viewed here. TORONTO – (October 9, 2020) – The COVID-19 pandemic has highlighted the critical importance of keeping Canada at the cutting edge of health technology to offer the best possible care to Canadians, while supporting economic growth. The Government of Canada is partnering with […]
Cerevel Therapeutics and Cyclica Announce Research Collaboration to Use Artificial Intelligence to Accelerate Discovery of Novel Medicines in Neuroscience
This post was adapted from its original source on Business Wire and can be viewed here. BOSTON & TORONTO – (July 27, 2020) – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables multi-objective, polypharmacology-informed design of drug molecules, today announced a research collaboration […]
FMC Corporation Collaborates with Cyclica to Improve Research Efficiency Using Artificial Intelligence
This post was adapted from its original source on PRNewswire and can be viewed here. PHILADELPHIA – (June 29, 2020) – FMC Corporation (NYSE: FMC) has entered into a collaboration with Cyclica, Inc, a leading biotechnology company specializing in artificial intelligence (AI) and computational biophysics, to accelerate and improve the efficiency of discovering new crop protection chemistry. This […]
Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future
This post was adapted from its original source on Business Wire and can be viewed here. Led by Drive Capital, the investment round includes Chiesi Farmaceutici, GreenSky Capital, and members of management. Proceeds will advance Cyclica’s AI-augmented, polypharmacology-enabled, drug discovery platforms, Ligand Design and Ligand Express, and accelerate commercial plans to advance a growing pipeline […]
Mannin and Cyclica Enter JV to Rapidly Develop COVID-19 Drugs
This post was adapted from its original source and can be viewed here. TORONTO & LEIPZIG – (April 20, 2020) – Mannin Research has entered a joint venture (JV) between Mannin GmbH, a German Mannin subsidiary, and Cyclica Inc. The Mannin – Cyclica JV will combine Mannin’s expertise and research capacity with Cyclica’s proprietary AI-augmented drug […]
Cyclica Forms Multi-Year and Multi-Project Drug Discovery Partnership with the Genome Institute of Singapore
This post was adapted from its original source on Business Wire and can be viewed here. TORONTO & SINGAPORE – (April 14, 2020) – Cyclica announces a multi-year and multi-project collaboration with the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and Research (A*STAR). Cyclica and GIS will carry […]
NeuroTheryX Partners with Cyclica to Launch NineteenGale Therapeutics to Advance First-In-Class Cannabinoid-Inspired Drugs for Neuropsychiatric Disorders
This post was adapted from its original source on Business Wire and can be viewed here. TORONTO – (March 19, 2020) – Following the successful early-stage validation of Cyclica’s Ligand Express® platform from an initial collaboration, NeuroTheryX Canada Ltd. (NeuroTheryX) and Cyclica, Inc. (Cyclica) form a new joint venture, NineteenGale Therapeutics (NineteenGale) to identify and develop novel […]
China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19
This post was adapted from its original source on Business Wire and can be viewed here. TORONTO & BEIJING – (March 5, 2020) – The epidemic of COVID-19 remains a prominent healthcare challenge, affecting more than 70 countries and regions over the world. This rapid widespread has made more countries realize the need for international […]
Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies with Greater Precision and Speed, under Project Nexus
This post was adapted from its original source on Business Wire and can be viewed here. TORONTO & SINGAPORE – (January 15, 2020) – AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biotechnology company committed to speedily developing affordable cancer therapies, and Cyclica, a Toronto-based biotechnology company leveraging AI and computational biophysics to decentralize drug discovery, today announced […]